A detailed history of First Horizon Corp transactions in Repligen Corp stock. As of the latest transaction made, First Horizon Corp holds 2 shares of RGEN stock, worth $313. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 60 96.67%
Holding current value
$313
Previous $11,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

SELL
$111.43 - $134.0 $6,462 - $7,772
-58 Reduced 96.67%
2 $0
Q1 2021

May 11, 2021

SELL
$180.37 - $226.26 $721 - $905
-4 Reduced 6.25%
60 $11,000
Q3 2020

Nov 12, 2020

BUY
$122.51 - $158.27 $7,840 - $10,129
64 New
64 $9,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.7B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track First Horizon Corp Portfolio

Follow First Horizon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Corp with notifications on news.